At the heart of the complaint are claims that SelectQuote misrepresented its Medicare Advantage sales practices. While the company publicly promoted its services as offering "unbiased advice" and ...
SelectQuote beat on earnings and on sales this morning. The insurance information provider earned a profit before paying out dividends for preferred stockholders. Free cash flow was deeply negative, ...
I'm upgrading SelectQuote to a buy rating after the stock's recent sharp fall. The federal government recently approved a 5.06% reimbursement rate increase for Medicare Advantage plans, which should ...
SAN FRANCISCO, Aug. 18, 2025 (GLOBE NEWSWIRE) -- After investors in SelectQuote (NYSE: SLQT) saw the price of their shares tumble over 19% on May 1, 2025 when the U.S. Department of Justice announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback